Objective: The objective was to evaluate depressive symptoms, sleep alterations and the role of gender and obesity in obstructive sleep apnea (OSA) patients.
Introduction
Obstructive sleep apnea (OSA) is an important clinical condition which is believed to affect at least 10% of the population, leading to high morbidity and mortality 1, 2 . Although depressive symptoms have been frequently described in association with OSA, a causal relationship between these two conditions is still under dispute 3, 4 . It has been shown that patients with major depressive disorders and post-traumatic stress are at increased risk of OSA 5 . Recently, a study has suggested that fatigue predicts depressive symptoms in patients with OSA 6 . This poses the important issue that depressive symptoms might be merely secondary to reduced welfare associated with fatigue. It must be kept in mind that psychiatric comorbidity in OSA may also affect patient quality of life and adherence to continuous positive airway pressure (CPAP).
Gender differences are important to guide therapy. Furthermore, the role of obesity in the genesis of depressive symptoms have not been fully appreciated in OSA. It has been shown that women tend to be under-diagnosed for OSA due to atypical symptoms or different clinical presentation. Overweight was associated with incident depression in women, while obesity were associated with incident depression in both genders 7, 8 . Women with OSA have been reported to weigh more, have more complaints of insomnia 9 , be more depressed and seek medical attention at an older age 8 . Thus, previous evidences indicate that gender differences related to OSA, sleep alterations and depressive symptoms exist and these may be important for clinical management.
Previous studies indicate that obesity, sleep alterations, depression and metabolic syndrome are connected [10] [11] [12] . It has been shown that short sleep contributes to weight gain and obesity 13 . Excessive daytime sleepiness (EDS) has also been linked to depression in the obese 14 . Among adolescents, anxiety and depressive symptoms are positively associated with increased body mass index (BMI) and body fat 15, 16 . Moreover, depression and anxiety have been linked to adverse health behaviors possibly interfering with daily activities and sleep hygiene 17 . Thus, psychological distress seems to be an important determinant of sleep quality and excessive daytime sleepiness in obese patients. It has been proposed that the presence/absence of psychological distress could provide the basis for understanding the different phenotypes related to obesity. In other words, it could help to explain why some individuals present poor sleep, fatigue and hyperactivity and others show better sleep and excessive daytime sleepiness 10 . All this confirm the close relationship between sleep alterations, obesity and anxiety/depression. Understanding the profile of these symptoms may guide disease modifying strategies.
The aim of this study was evaluate depressive symptoms, sleep alterations and the role of gender and obesity in obstructive sleep apnea (OSA) patients.
Methods

Study population
This is a cross-sectional evaluation of 150 consecutive patients referred for polysomnography with clinical suspicion of OSA. Cases with cancer, severe neurological, renal, hepatic, lung or cardiac diseases were excluded. Five individuals declined to participate in the study and five other were considered too ill to participate. Among the latter, three had dementia and two had suffered a recent ischemic stroke. Thus, the final sample consisted of 140 patients. After overnight polysomnography, those with Apnea-Hypopnea Index (AHI) ≤5 events per hour of sleep were diagnosed as snorers, 5<AHI<15 as mild, 15<AHI<30 as moderate and those with AHI>30 as severe OSA. For comparison, all cases were grouped as snorers/mild OSA (AHI≤15) and as moderate/severe OSA (AHI>15). Cases included in the study were not involved in shift work and did not have recent hospitalizations for the last three months. A structured interview was conducted prior to polysomnography. The protocol was approved by the local Research Ethics Committee (COMEPE 093.12.08) and written informed consent was obtained in all cases.
Procedures
Demographic and clinical data were recorded using a closed-question data collection instrument obtained in a face to face interview. Body mass index was calculated as the ratio between weight (Kg) and squared height (m 2 ). A special emphasis was made on the use of medication in the last 30 days.
Depressive symptoms were evaluated by the Hamilton Rating Scale for Depression-17 item (HRSD) 18 . This scale takes into consideration several aspects such as anxiety (psychological and somatic), depressed mood, insomnia subdivided in early, middle and late insomnia among other mood related questionings. Daytime somnolence was assessed by the Epworth sleepiness scale (ESS), a validated questionnaire containing eight items that asks for expectation of dozing in eight hypothetical situations. Dozing probability ratings range from zero (no probability) to three (high probability). An ESS score of 10 or more indicates excessive daytime sleepiness 19 . Comorbidity severity was evaluated with the Charlson Comorbidity Index (CCI) 20 .
Standard overnight polysomnography was performed on a digital polygraph (ALICE II®, Respironics Inc.). Polysomnographic recordings were set to begin at 10 p.m. (lights-out) and end at 6 a.m. (lights-on). Monitored variables included: electroencephalogram (C3, C4, O1, O2 referenced to contralateral ear electrodes), bilateral electrooculograms, submental electromyogram (EMG), two-lead electrocardiogram, pulse oximetry, bilateral tibialis EMG and airflow, using a nasal/oral thermocouple. Body position and thoracic and abdominal movements (inductance plethysmography) were also recorded.
Sleep staging was performed by 30-s epochs, according to standard procedures 21 . Polysomnographyderived parameters evaluated were AHI, minimum oxygen saturation (SaO 2 min), sleep latency, sleep efficiency, rapid eye movement (REM) sleep latency, amount of REM sleep (% of total sleep time), amount of non-rapid eye movement (NREM) sleep (% of total sleep time), number of arousals and periodic leg movements. Arousal analysis and scoring of respiratory events during sleep were performed according to standard criteria. Apneas were defined as cessation of airflow for 10 s or more and hypopneas as a reduction of inspiratory air flow of 50% or more associated with either oxygen desaturation of >3% or an arousal. The analysis of the components of the HDRS showed that the most important complaints are somatic and psychological anxiety, followed by work and activities complaints, late insomnia, somatic symptoms, depressed mood, hypochondriasis and genital symptoms (Figure 1) . Among all cases, 105 patients (73.4%) were overweight (25<BMI≤30) and 42 (29%) were obese (BMI>30). In eight cases (5.5%), BMI was greater than 40. Obese patients (N=96) showed higher HDRS scores (8.52±5.0 vs 6 .38±5.0, p=0.02). Profile of depressive symptoms was similar for obese and non-obese patients. In all cases, BMI was positively correlated with HDRS scores (r= 0.246, p= 0.02) (Figure 2) . Seventeen patients (12.1%) used sedatives, mostly benzodiazepine, and eight cases (5.7%) were on antidepressants (selective inhibitors of serotonin reuptake).
Statistical analysis
Discussion
There are gender related differences in sleep apnea: obstructive sleep apnea is more common in men 22 . Similarly, in this series of cases and according to OSA severity, moderate/severe OSA predominantly affected men. In the present work, women with mild OSA, had more severe depressive symptoms. In partial agreement, depression was more prevalent in women with OSA than in men [23] [24] [25] . This needs attention considering that patients with comorbid conditions such as anxiety and depression are increased risk of cardiovascular disease and mortality 26, 27 . Other works confirm that women with OSA may have greater risk for hypertension and endothelial dysfunction 28 .
Depressive symptoms and sleep parameters, i.e. apnea+hypopnea index, SpO 2 min and HDRS scores, did not correlate. In corroboration, previous studies showed that depressive symptoms were not correlated with OSA severity 24, 29 . In this work, BMI measures correlated with the HDRS scores. Studies involving OSA, obesity, gender and depression are still controversial. Hence, it is important and necessary to clarify the association among these factors for a proper clinical management.
Our results showed a positive correlation among the BMI, apnea+hypopnea index, arousals index and SpO 2 min. Furthermore, obesity was associated with more severe depressive symptoms. In agreement with a previous study, patients with OSA, overweight and obesity had more depression 30 .
Given the present evidence and considering the high prevalence of obesity, depression and poor quality of life in OSA patients, probably, a multitherapy approach to treat obesity, OSA and depressive symptoms is necessary. For instance, a survey that evaluated assessment of bariatric surgery efficacy on OSA determined a significant improvement in AHI/ AI/RDI occurred after surgery, in addition to the foreseeable reduction in body mass index 31 . Respiratory 32, 33 or mandibular advancement device (MADs) 32 . Furthermore, evaluating depressive symptoms is necessary before proceeding with non-pharmacological and/or pharmacological support. Presently, patients with OSA presented some specific psychological characters of mood symptoms. Somatic and psychological anxiety followed by work and activities complaints, were the most important depressive symptoms domains in OSA patients. Importantly, late insomnia was predominant over middle and early insomnia. Similarly, others studies reported a strong association between OSA and somatic syndromes, anxiety and insomnia [34] [35] [36] [37] . Women, habitual snorers or with mild OSA, presented more somatic anxiety: obese patients had more severe symptoms. These findings reinforce the importance of gender and obesity in the manifestation of depressive symptoms. The role of anxiety in the determination of mood symptoms as presented here is relevant considering that a recent study demonstrated that depression and anxiety were associated with decreased health-related quality of life scales (HRQL) 33, 38 . Depressive symptoms are also important as they seem to be a major contributor to mental and physical quality of life 38 .
Interestingly, ESS scores were correlated with arousals index and SpO2min values. However, sleepiness severity (ESS scores) were not correlated to apnea+hypopnea index. In agreement, polysomnographic nocturnal hypoxaemic parameters were previously correlated with sleepiness measures (ESS scores) 39 .
In our findings, women with moderate/severe OSA showed greater comorbidity severity than men. According with a study that included a large number of patients with OSA, a strongly association between OSA and significant comorbidities was demonstrated. Type 2 diabetes and ischaemic heart disease were more prevalent in men; however, hypertension was more common in women 23 .
We accuse knowledge limitations. Sleepiness was only assessed by a subjective measure. However, it has been argued that objective and subjective measures of sleepiness represent different constructs. As a positive aspect, ESS is largely used in clinical studies.
Conclusion
The profile of depressive symptoms in OSA is determined by anxiety, both somatic and psychological, followed by work and activities complaints, late insomnia, somatic symptoms and depressed mood. Depressive symptoms are more severe in women and in obese patients and, in general, are overlooked and undertreated.
